The in vivo and in vitro efficiency and efficacy of PGD for aneuploidy

Molecular and Cellular Endocrinology

Volumn 183, Issue SUPPL. 1, 2001, Pages

  Gianaroli, Luca ^a   Magli, M C ^a   Ferraretti, A P ^a  

^a SISMER   (Italy)

Author keywords

Aneuploidy; Implantation rate; Multicolour FISH; Poor prognosis patients; Preimplantation genetic diagnosis

Indexed keywords

ANEUPLOIDY; ARTICLE; BLASTOMERE; EMBRYO; EMBRYO DEVELOPMENT; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; PREIMPLANTATION EMBRYO; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; ADULT; CHROMOSOME DISORDER; COMPARATIVE STUDY; CYTOLOGY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GENETIC DISORDER; KARYOTYPING; MATERNAL AGE; METHODOLOGY; NIDATION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY RATE; PRODUCTIVITY; PROGNOSIS; TRISOMY;

ADULT; ANEUPLOIDY; BLASTOMERES; CHROMOSOME DISORDERS; COMPARATIVE STUDY; EFFICIENCY; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GENETIC DISEASES, INBORN; HUMAN; IN SITU HYBRIDIZATION, FLUORESCENCE; IN VITRO; KARYOTYPING; MATERNAL AGE 35 AND OVER; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREIMPLANTATION DIAGNOSIS; PROGNOSIS; TRISOMY;

EID: 0035935212     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00570-6     Document Type: Article

References (19)

1. PGD of aneuploidy: were we looking at the wrong chromosomes?
2. Relationship of timing agonist administration in the cycle phase to the ovarian response to gonadotropins in the long-down regulation protocols for assisted reproductive technologies
3. Prolonged sperm-oocyte exposure and high sperm concentration affect human embryo viability and pregnancy rate
4. Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilisation by avoiding the transfer of chromosomally abnormal embryos
5. Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy?
6. Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilisation with a poor prognosis: identification of the categories for which it should be proposed
7. Advantages of day four embryo transfer in patients undergoing preimplantation genetic diagnosis of aneuploidy
8. Preimplantation diagnosis after assisted reproduction techniques for genetically determined male infertility
9. Pregnancies from biopsied human preimplantation embryos sexed by Y-specified DNA amplification
10. Incidence of chromosomal abnormalities from a morphologically normal cohort of embryos in poor prognosis patients
11. Impact of blastomere biopsy and cryopreservation techniques on human embryo viability
12. Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro
13. Diagnosis of major chromosome aneuploidies in human preimplantation embryos
14. Scoring criteria for preimplantation genetic diagnosis of numerical abnormalities for chromosomes X,Y,13,16,18, and 21
15. Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY,13,14,15,16,18,21,22
16. Positive outcome after preimplantation diagnosis of human embryos
17. Increased chromosomal abnormalities in human preimplantation embryos after in vitro fertilisation in patients with recurrent miscarriage
18. Maternal age specific risks for trisomies at 9-14 weeks' gestation
19. Preimplantation diagnosis of common aneuploidies in fertile couples of advanced maternal age